Trial Reporting in ClinicalTrials.gov — The Final Rule

Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors

De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241 · see citing works

Increasing value and reducing waste: addressing inaccessible research

Chan, A.-W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., Krumholz, H. M., Ghersi, D., & van der Worp, H. B. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62296-5 · Cited by 887 · see citing works

The ClinicalTrials.gov Results Database — Update and Key Issues

Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838 · see citing works

Compliance with Results Reporting at ClinicalTrials.gov

Anderson, M. L., Chiswell, K., Peterson, E. D., Tasneem, A., Topping, J., & Califf, R. M. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1409364 · Cited by 380 · see citing works

Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals

Riveros, C., Dechartres, A., Perrodeau, E., Haneef, R., Boutron, I., & Ravaud, P. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001566 · Cited by 269 · see citing works

Issues in the Registration of Clinical Trials

Zarin, D. A., Ide, N. C., Tse, T., Harlan, W. R., West, J. C., & Lindberg, D. A. B. (2007) · JAMA · doi:10.1001/jama.297.19.2112 · Cited by 228 · see citing works

Toward a New Era of Trust and Transparency in Clinical Trials.

Hudson, K., Lauer, M., & Collins, F. (2016) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2016.14668 · Cited by 132 · see citing works

The Evolution of Trial Registries and Their Use to Assess the Clinical Trial Enterprise

Dickersin, K. (2012) · JAMA · doi:10.1001/jama.2012.4230 · Cited by 127 · see citing works

The Proposed Rule for U.S. Clinical Trial Registration and Results Submission

Zarin, D. A., Tse, T., & Sheehan, J. (2014) · New England Journal of Medicine · doi:10.1056/nejmsr1414226 · Cited by 102 · see citing works

Clinical Trials Registration and Results Information Submission. Final rule.

(2016) · PubMed · Cited by 101 · see citing works

Trial-Results Reporting and Academic Medical Centers

Zarin, D. A., Tse, T., & Ross, J. S. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505965 · Cited by 13 · see citing works

PRISMA-S: An Extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., & Koffel, J. (2019) · doi:10.31219/osf.io/sfc38 · Cited by 3,696 · see citing works

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., PRISMA-S Group, Blunt, H., Brigham, T., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01542-z · Cited by 3,714 · see citing works

Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics

Wang, Y., Zhang, S., Li, F., Zhou, Y., Zhang, Y., Wang, Z., Zhang, R., Zhu, J., Ren, Y., Tan, Y. C., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz981 · Cited by 794 · see citing works

Alzheimer's disease drug development pipeline: 2018

Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.009 · Cited by 697 · see citing works

Alzheimer's disease drug development pipeline: 2017

Cummings, J., Lee, G., Mortsdorf, T., Ritter, A., & Zhong, K. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.05.002 · Cited by 549 · see citing works

PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews

Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., & PRISMA-S Group (2021) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2021.962 · Cited by 492 · see citing works

Race/ethnicity reporting and representation in US clinical trials: A cohort study

Turner, B. E., Steinberg, J. R., Weeks, B. T., Rodríguez, F., & Cullen, M. R. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100252 · Cited by 402 · see citing works

CONSORT-SPI 2018 explanation and elaboration: guidance for reporting social and psychological intervention trials

O. B. O. T. C.-S. G., Grant, S., Mayo-Wilson, E., Montgomery, P., Macdonald, G., Michie, S., Hopewell, S., & Moher, D. (2018) · Trials · doi:10.1186/s13063-018-2735-z · Cited by 348 · see citing works

Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study

DeVito, N. J., Bacon, S., & Goldacre, B. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33220-9 · Cited by 336 · see citing works

Considering bias and conflicts of interest among the included studies

Boutron, I., Page, M. J., Higgins, J. P., Altman, D. G., Lundh, A., Hróbjartsson, A., & on behalf of the Cochrane Bias Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch7 · Cited by 258 · see citing works

Update on Trial Registration 11 Years after the ICMJE Policy Was Established

Zarin, D. A., Tse, T., Williams, R. J., & Rajakannan, T. (2017) · New England Journal of Medicine · doi:10.1056/nejmsr1601330 · Cited by 242 · see citing works

How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider

Tse, T., Fain, K. M., & Zarin, D. A. (2018) · BMJ · doi:10.1136/bmj.k1452 · Cited by 194 · see citing works

SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials

Hróbjartsson, A., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081660 · Cited by 171 · see citing works

A historical review of publication bias

Marks‐Anglin, A., & Chen, Y. (2020) · Research Synthesis Methods · doi:10.1002/jrsm.1452 · Cited by 165 · see citing works

10-Year Update on Study Results Submitted to ClinicalTrials.gov

Zarin, D. A., Fain, K. M., Dobbins, H. D., Tse, T., & Williams, R. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmsr1907644 · Cited by 150 · see citing works

A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis

Kirkham, J. J., Clarke, M. J., & Williamson, P. R. (2017) · BMJ · doi:10.1136/bmj.j2262 · Cited by 146 · see citing works

Toward a New Era of Trust and Transparency in Clinical Trials.

Hudson, K., Lauer, M., & Collins, F. (2016) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2016.14668 · Cited by 132 · see citing works

Adverse events in people taking macrolide antibiotics versus placebo for any indication

Hansen, M. P., Scott, A. M., McCullough, A. R., Thorning, S., Aronson, J. K., Beller, E., Glasziou, P., Hoffmann, T., Clark, J. M., & Mar, C. D. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011825.pub2 · Cited by 138 · see citing works

Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., & Dickersin, K. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.05.007 · Cited by 131 · see citing works

Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005

Zwierzyna, M., Davies, M., Hingorani, A. D., & Hunter, J. (2018) · BMJ · doi:10.1136/bmj.k2130 · Cited by 126 · see citing works

Practical guidance for using multiple data sources in systematic reviews and meta‐analyses (with examples from the <scp>MUDS</scp> study)

Mayo‐Wilson, E., Li, T., Fusco, N., Dickersin, K., & for the MUDS investigators (2018) · Research Synthesis Methods · doi:10.1002/jrsm.1277 · Cited by 114 · see citing works

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.04.020 · Cited by 109 · see citing works

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy

Mayo-Wilson, E., Li, T., Fusco, N., Bertizzolo, L., Canner, J. K., Cowley, T., Doshi, P., Ehmsen, J., Gresham, G., Guo, N., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.07.014 · Cited by 108 · see citing works

Registration of published randomized trials: a systematic review and meta-analysis

Trinquart, L., Dunn, A. G., & Bourgeois, F. T. (2018) · BMC Medicine · doi:10.1186/s12916-018-1168-6 · Cited by 105 · see citing works

Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses

Baudard, M., Yavchitz, A., Ravaud, P., Perrodeau, E., & Boutron, I. (2017) · BMJ · doi:10.1136/bmj.j448 · Cited by 107 · see citing works

The need for transparency of clinical evidence for medical devices in Europe

Fraser, A. G., Butchart, E. G., Szymański, P., Caiani, E. G., Crosby, S., Kearney, P., & de Werf, F. V. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31270-4 · Cited by 103 · see citing works

Promoting public access to clinical trial protocols: challenges and recommendations

Chan, A.-W., & Hróbjartsson, A. (2018) · Trials · doi:10.1186/s13063-018-2510-1 · Cited by 84 · see citing works

Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019

Gresham, G. K., Meinert, J. L., Gresham, A. G., & Meinert, C. L. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.14682 · Cited by 84 · see citing works

Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications

Chan, A.-W., Pello, A., Kitchen, J., Axentiev, A., Virtanen, J. I., Liu, A., & Hemminki, E. (2017) · JAMA · doi:10.1001/jama.2017.13001 · Cited by 78 · see citing works

Race and ethnicity reporting for clinical trials in ClinicalTrials.gov and publications

Fain, K. M., Nelson, J. T., Tse, T., & Williams, R. J. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106237 · Cited by 74 · see citing works

Review and publication of protocol submissions to Trials – what have we learned in 10 years?

Li, T., Boutron, I., Salman, R. A.-S., Cobo, E., Flemyng, E., Grimshaw, J. M., & Altman, D. G. (2017) · Trials · doi:10.1186/s13063-016-1743-0 · Cited by 66 · see citing works

Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020

Gresham, G. K., Meinert, J. L., Gresham, A. G., Piantadosi, S., & Meinert, C. L. (2022) · Trials · doi:10.1186/s13063-022-06569-2 · Cited by 66 · see citing works

Harms in Systematic Reviews Paper 1: An introduction to research on harms

Qureshi, R., Mayo-Wilson, E., & Li, T. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.10.023 · Cited by 63 · see citing works

Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events

Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.04.022 · Cited by 63 · see citing works

Time to improve the reporting of harms in randomized controlled trials

Junqueira, D. R., Phillips, R., Zorzela, L., Golder, S., Loke, Y. K., Moher, D., Ioannidis, J. P. A., & Vohra, S. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.04.020 · Cited by 65 · see citing works

Time for NIH to lead on data sharing

Sim, I., Stebbins, M., Bierer, B. E., Butte, A. J., Drazen, J. M., Dzau, V. J., Hernandez, A. F., Krumholz, H. M., Lo, B., Munos, B. H., et al. (2020) · Science · doi:10.1126/science.aba4456 · Cited by 63 · see citing works

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies

Miller, J. E., Wilenzick, M., Ritcey, N., Ross, J. S., & Mello, M. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017917 · Cited by 62 · see citing works

Eligibility criteria in NIH-funded clinical trials: Can adults with intellectual disability get in?

McDonald, K., Schwartz, A., & Sabatello, M. (2022) · Disability and health journal · doi:10.1016/j.dhjo.2022.101368 · Cited by 61 · see citing works

Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis

Bolton, M. J., Hodkinson, A., Boda, S., Mould, A., Panagioti, M., Rhodes, S., Riste, L., & van Marwijk, H. (2019) · BMC Medicine · doi:10.1186/s12916-018-1242-0 · Cited by 59 · see citing works

Race and Ethnicity Reporting and Representation in Pediatric Clinical Trials

Brewster, R., Steinberg, J. R., Magnani, C. J., Jackson, J., Wong, B. O., Valikodath, N., MacDonald, J., Li, A., Marsland, P., Goodman, S. N., et al. (2023) · PEDIATRICS · doi:10.1542/peds.2022-058552 · Cited by 58 · see citing works

Key indicators of phase transition for clinical trials through machine learning

Feijoo, F., Palopoli, M., Bernstein, J., Siddiqui, S., & Albright, T. E. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2019.12.014 · Cited by 59 · see citing works

Modeling community standards for metadata as templates makes data FAIR

Musen, M. A., O’Connor, M. J., Schultes, E., Martínez-Romero, M., Hardi, J., & Graybeal, J. B. (2022) · Scientific Data · doi:10.1038/s41597-022-01815-3 · Cited by 54 · see citing works

P-hacking in clinical trials and how incentives shape the distribution of results across phases

Adda, J., Decker, C., & Ottaviani, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919906117 · Cited by 54 · see citing works

Automatic extraction of quantitative data from ClinicalTrials.gov to conduct meta-analyses

Pradhan, R., Hoaglin, D. C., Cornell, M., Liu, W., Wang, V., & Yu, H. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.08.023 · Cited by 52 · see citing works

Availability of Investigational Medicines Through the US Food and Drug Administration’s Expanded Access and Compassionate Use Programs

Puthumana, J., Miller, J. E., Kim, J., & Ross, J. S. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0283 · Cited by 45 · see citing works

Characteristics and trends of clinical trials funded by the National Institutes of Health between 2005 and 2015

Gresham, G. K., Ehrhardt, S., Meinert, J. L., Appel, L. J., & Meinert, C. L. (2017) · Clinical Trials · doi:10.1177/1740774517727742 · Cited by 43 · see citing works

Machine Learning with Statistical Imputation for Predicting Drug Approval

Lo, A. W., Siah, K. W., & Wong, C. H. (2019) · Harvard Data Science Review · doi:10.1162/99608f92.5c5f0525 · Cited by 42 · see citing works

Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on ClinicalTrials.gov

Zippel, C., Ronski, S. C., Bohnet-Joschko, S., Giesel, F. L., & Kopka, K. (2020) · Pharmaceuticals · doi:10.3390/ph13010012 · Cited by 42 · see citing works

Conditional equivalence testing: An alternative remedy for publication bias

Campbell, H., & Gustafson, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195145 · Cited by 40 · see citing works

Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

Catalá-López, F., Aleixandre-Benavent, R., Caulley, L., Hutton, B., Tabarés-Seisdedos, R., Moher, D., & Alonso-Arroyo, A. (2020) · Trials · doi:10.1186/s13063-019-3944-9 · Cited by 38 · see citing works

Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications

Lagunas‐Rangel, F. A. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1579054 · Cited by 39 · see citing works

Clinical trial registration and reporting: a survey of academic organizations in the United States

Mayo‐Wilson, E., Heyward, J., Keyes, A., Reynolds, J., White, S., Atri, N., Alexander, G. C., Omar, A., & Ford, D. E. (2018) · BMC Medicine · doi:10.1186/s12916-018-1042-6 · Cited by 39 · see citing works

Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials

Regnante, J. M., Richie, N. A., Fashoyin‐Aje, L. A., Hall, L. L., Highsmith, Q., Louis, J. A., Turner, K. C., Hoover, S. C., Lee, S. J. C., González, E., et al. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100532 · Cited by 39 · see citing works

Underrecording and underreporting of participant ethnicity in clinical trials is persistent and is a threat to inclusivity and generalizability

Wallace, N. D., O'Keeffe, S., Gardner, H., & Shiely, F. (2023) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2023.08.008 · Cited by 37 · see citing works

Efficient design of clinical trials and epidemiological research: is it possible?

Lauer, M. S., Gordon, D., Wei, G. S., & Pearson, G. D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.60 · Cited by 36 · see citing works

Availability of study protocols for randomized trials published in high-impact medical journals: A cross-sectional analysis

Spence, O., Hong, K., Onwuchekwa Uba, R., & Doshi, P. (2020) · Clinical Trials · doi:10.1177/1740774519868310 · Cited by 37 · see citing works

Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events

Mayo‐Wilson, E., Fusco, N., Hong, H., Li, T., Canner, J. K., & Dickersin, K. (2019) · Trials · doi:10.1186/s13063-019-3581-3 · Cited by 37 · see citing works

Disparities in Breast, Lung, and Cervical Cancer Trials Worldwide

Ramaswami, R., Paulino, E., Barrichello, A. P. D. C., Nogueira‐Rodrigues, A., Bukowski, A., Louis, J. S., & Goss, P. E. (2018) · Journal of Global Oncology · doi:10.1200/jgo.17.00226 · Cited by 35 · see citing works

Transparent, Open, and Reproducible Prevention Science

Grant, S., Wendt, K. E., Leadbeater, B. J. R., Supplee, L. H., Mayo‐Wilson, E., Gardner, F. E. M., & Bradshaw, C. P. (2022) · Prevention Science · doi:10.1007/s11121-022-01336-w · Cited by 36 · see citing works

Publicising trial results before peer review

Fralick, M., & Sacks, C. A. (2019) · BMJ · doi:10.1136/bmj.l556 · Cited by 33 · see citing works

Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes

Connell, C. M., Raby, S., Beh, I., Flint, T. R., Williams, E. H., Fearon, D. T., Jodrell, D. I., & Janowitz, T. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx181 · Cited by 32 · see citing works

Analysis of Rates of Completion, Delays, and Participant Recruitment in Randomized Clinical Trials in Surgery

Shadbolt, C., Naufal, E. R., Bunzli, S., Price, V., Rele, S., Schilling, C. G., Thuraisingam, S., Lohmander, S. L., Balogh, Z. J., Clarke, P., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.50996 · Cited by 33 · see citing works

Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Agoramoorthy, G., & Lee, S. (2021) · Vaccines · doi:10.3390/vaccines9060600 · Cited by 30 · see citing works

Examining Provisions Related to Consent in the Revised Common Rule

Sugarman, J. (2017) · The American Journal of Bioethics · doi:10.1080/15265161.2017.1329483 · Cited by 32 · see citing works

Open science: The open clinical trials data journey

Rockhold, F. W., Bromley, C. M., Wagner, E. K., & Buyse, M. E. (2019) · Clinical Trials · doi:10.1177/1740774519865512 · Cited by 31 · see citing works

Trends in mental health clinical research: Characterizing the ClinicalTrials.gov registry from 2007–2018

Wortzel, J. R., Turner, B. E., Weeks, B. T., Fragassi, C., Ramos, V., Truong, T., Li, D., Sahak, O., & Lee, H. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233996 · Cited by 31 · see citing works

Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011

Doshi, P., Hur, P., Jones, M., Albarmawi, H., Jefferson, T., Morgan, D. J., Spears, P. A., & Powers, J. H. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3820 · Cited by 30 · see citing works

Adherence to guidance on registration of randomised controlled trials published in Anaesthesia

El‐Boghdadly, K., Wiles, M. D., Atton, S., & Bailey, C. R. (2018) · Anaesthesia · doi:10.1111/anae.14103 · Cited by 32 · see citing works

Geographic Access Disparities to Clinical Trials in Diabetic Eye Disease in the United States

Soares, R. R., Parikh, D. A., Shields, C. N., Peck, T. J., Gopal, A. D., Sharpe, J. E., & Yonekawa, Y. (2020) · Ophthalmology Retina · doi:10.1016/j.oret.2020.12.006 · Cited by 30 · see citing works

Recent advances and new discoveries in the pipeline of the treatment of primary spinal tumors and spinal metastases: a scoping review of registered clinical studies from 2000 to 2020

Furlan, J. C., Wilson, J. R., Massicotte, E. M., Sahgal, A., & Fehlings, M. G. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab214 · Cited by 30 · see citing works

Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases

Ikonomou, L., Wagner, D. E., Turner, L. G., & Weiss, D. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201812-890cme · Cited by 28 · see citing works

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics

Cole, M., & Seabrook, G. R. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12009 · Cited by 28 · see citing works

Evaluation of Compliance With Legal Requirements Under the FDA Amendments Act of 2007 for Timely Registration of Clinical Trials, Data Verification, Delayed Reporting, and Trial Document Submission

DeVito, N., & Goldacre, B. M. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.2036 · Cited by 28 · see citing works

Characteristics of mental health trials registered in ClinicalTrials.gov.

Arnow, K. D., King, A., & Wagner, T. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112552 · Cited by 10 · see citing works

Is Open Science the Future of Drug Development?

Shaw, D. L. (2017) · PubMed Central · Cited by 27 · see citing works

Effect of Non-Steroidal Anti-Inflammatory Drugs on Sport Performance Indices in Healthy People: a Meta-Analysis of Randomized Controlled Trials

Cornu, C., Grangé, C., Regalin, A., Munier, J., Ounissi, S., Reynaud, N., Kassaï, B., Sallet, P., & Nony, P. (2020) · Sports Medicine - Open · doi:10.1186/s40798-020-00247-w · Cited by 27 · see citing works

Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law

Kumari, S., Mohan, A., & Saberwal, G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234925 · Cited by 27 · see citing works

The obstetrical research landscape: a cross-sectional analysis of clinical trials from 2007-2020

Steinberg, J. R., Weeks, B. T., Reyes, G., Fitzgerald, A. C., Zhang, W. Y., Lindsay, S. E., Anderson, J. N., Chan, K. S., Richardson, M. T., Magnani, C. J., et al. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100253 · Cited by 27 · see citing works

BRIDG: a domain information model for translational and clinical protocol-driven research

Becnel, L. B., Hastak, S., Hoef, W. V., Milius, R. P., Slack, M. A., Wold, D., Glickman, M. L., Brodsky, B., Jaffe, C., Kush, R. D., et al. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx004 · Cited by 27 · see citing works

Time to publication of oncology trials and why some trials are never published

Chapman, P. B., Liu, N. J., Zhou, Q. C., Iasonos, A. E., Hanley, S., Bosl, G. J., & Spriggs, D. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184025 · Cited by 27 · see citing works

Standards for design and measurement would make clinical research reproducible and usable

Dickersin, K., & Mayo‐Wilson, E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708273114 · Cited by 26 · see citing works

Supervised Learning for the Prediction of Firm Dynamics

Bargagli-Stoffi, F. J., Niederreiter, J., & Riccaboni, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-66891-4_2 · Cited by 26 · see citing works

Legal regulations, ethical guidelines and recent policies to increase transparency of clinical trials

Borysowski, J., Wnukiewicz‐Kozłowska, A., & Górski, A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14223 · Cited by 26 · see citing works

A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer

Gupta, S., Silveira, D. A., Piedade, G. P. S., Ostrowski, M. P., Mombach, J. C. M., & Hashimoto, R. F. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.10.008 · Cited by 25 · see citing works

Health Research Participation, Opportunity, and Willingness Among Minority and Rural Communities of Arkansas

McElfish, P. A., Long, C. R., Selig, J. P., Rowland, B., Purvis, R. S., James, L. P., Holland, A., Felix, H. C., & Narcisse, M. (2018) · Clinical and Translational Science · doi:10.1111/cts.12561 · Cited by 24 · see citing works

Sharing individual participant data: through a systematic reviewer lens

Rydzewska, L. H. M., Stewart, L. A., & Tierney, J. F. (2022) · Trials · doi:10.1186/s13063-021-05787-4 · Cited by 24 · see citing works

Knowledge bases and software support for variant interpretation in precision oncology

Borchert, F., Möck, A., Tomczak, A., Hügel, J., Alkarkoukly, S., Knurr, A., Volckmar, A., Stenzinger, A., Schirmacher, P., Debus, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab134 · Cited by 24 · see citing works

FDAAA TrialsTracker: A live informatics tool to monitor compliance with FDA requirements to report clinical trial resultsPreprint

DeVito, N., Bacon, S., & Goldacre, B. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/266452 · Cited by 23 · see citing works

Recent advances of automated methods for searching and extracting genomic variant information from biomedical literature

Lee, K., Wei, C.-H., & Lu, Z. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa142 · Cited by 23 · see citing works

Overview of Clinical Trials on Type 2 Diabetes Mellitus: A Comprehensive Analysis of the ClinicalTrials.gov Database

Long, J., Liang, R., Zheng, Q., Yuan, G., Xin, Z., Chen, X., Lai, F., & Liu, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s288065 · Cited by 22 · see citing works

Systematic comparison of Mendelian randomisation studies and randomised controlled trials using electronic databases

Sobczyk, M., Zheng, J., Smith, G. D., & Gaunt, T. R. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072087 · Cited by 24 · see citing works

Publication and Dissemination of Results in Clinical Trials of Neurology

Sreekrishnan, A., Mampre, D. M., Ormseth, C. H., Miyares, L. C., Leasure, A. C., Ross, J. S., & Sheth, K. N. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0674 · Cited by 23 · see citing works

Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes

Welsch, C. A., Rust, W. L., & CSETE, M. E. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0156 · Cited by 22 · see citing works

Connecting the public with clinical trial options: The ResearchMatch Trials Today tool

Pulley, J. M., Jerome, R. N., Bernard, G. R., Olson, E. J., Tan, J. K. G., Wilkins, C. H., & Harris, P. A. (2018) · Journal of Clinical and Translational Science · doi:10.1017/cts.2018.327 · Cited by 20 · see citing works

Semantic categorization of Chinese eligibility criteria in clinical trials using machine learning methods

Zong, H., Yang, J.-X., Zhang, Z., Li, Z., & Zhang, X. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01487-w · Cited by 22 · see citing works

Publication of Results of Registered Trials With Published Study Protocols, 2011-2022

Vorland, C. J., Brown, A. W., Halil Kilicoglu, B., Ying, X., & Mayo‐Wilson, E. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.50688 · Cited by 20 · see citing works

Caveat emptor: the combined effects of multiplicity and selective reporting

Li, T., Mayo‐Wilson, E., Fusco, N., Hong, H., & Dickersin, K. (2018) · Trials · doi:10.1186/s13063-018-2888-9 · Cited by 21 · see citing works

Co-opting of ClinicalTrials.gov by patient-funded studies

Wagner, D. E., Turner, L. G., Panoskaltsis‐Mortari, A., Weiss, D. J., & Ikonomou, L. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30242-x · Cited by 20 · see citing works

Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platform

Guedj, M., Swindle, J., Hamon, A., Hubert, S., Desvaux, E., Laplume, J., Xuereb, L., Lefèbvre, C., Haudry, Y., Gabarroca, C., et al. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2095368 · Cited by 23 · see citing works

Focus on sharing individual patient data distracts from other ways of improving trial transparency

Hoffmann, T., Glasziou, P., Beller, E., Goldacre, B. M., & Chalmers, I. (2017) · BMJ · doi:10.1136/bmj.j2782 · Cited by 20 · see citing works

Remuneration for clinical trials.

(1966) · Europe PMC (PubMed Central)

Letter: Fee schedules and workloads.

Cameron, D. I., Stewart, J. D., Slack, R. C., & Lewis, C. L. (1975) · PubMed Central · Cited by 5 · see citing works

© Society for Clinical Trials 2007 10.1177/1740774507079434 ARTICLE Clinical Trials 2007; 4: 258–263

(2016)

[The fiscal regulation of physicians applying conventional fees].

Mignon, J. (1963) · PubMed

Association of the FDA Amendment Act with trial registration, publication, and outcome reporting

Phillips, A. T., Desai, N. R., Krumholz, H. M., Zou, C. X., Miller, J. E., & Ross, J. S. (2017) · Trials · doi:10.1186/s13063-017-2068-3 · Cited by 61 · see citing works